Director, Human Cell Therapy Laboratory
Hematology
Dr. Dennis A. Gastineau, MD
|
|
Give Review
Dennis Gastineau is an expert in the field of Hematology. He graduated from Mayo Medical School. Mayo Medical School has a rank of 27 in research and a 42 in primary care Dennis Gastineau is also a published doctor. He has 43 publication published. The most recent publication is: Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients. Dennis Gastineau accepts Medicare payments and is registered with Medicare.gov.
Publications
- ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and Acute myeloid leukemia undergoing HLA-matched per...
- Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
- Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
- Long-term outcome of patients with multiple Myeloma-related advanced renal failure following auto-SCT.
- Self-Regulatory Fatigue, Quality of Life, Health Behaviors, and Coping in Patients with Hematologic Malignancies.
- Accuracy of self-reported tobacco use status among hematopoietic SCT patients.
- Infusion technique of hematopoietic progenitor cells and related adverse events.
- Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple Myeloma following lenalidomide-based initial therapy.
- The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
- Incidence of Supraventricular Arrhythmias during Autologous Peripheral Blood Stem Cell Transplantation.
- Discordant CD34+ cell results in Peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatm...
- Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myelom...
- Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous Peripheral blood stem cell mobilization.
- Association of an increased frequency of CD14(+) HLA-DR(lo/neg) monocytes with decreased time to progression in Chronic lymphocytic leukaemia (CLL).
- Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.
- Self-regulatory Fatigue in Hematologic Malignancies: Impact on Quality of Life, Coping, and Adherence to Medical Recommendations.
- Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple Myeloma.
- Cancer-related TTP and considerations of plasma exchange.
- Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin Lymphoma.
- A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple Myeloma.
- Systemic Immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.
- Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.
- Comparison of Coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
- Autologous stem cell transplant in 716 patients with multiple Myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisc...
- A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
- Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
- Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin Lymphoma: a prospective study.
- Relationship between depth of response and outcome in multiple Myeloma.
- Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
- AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin Lymphoma.
- Flow cytometric detection of circulating Myeloma cells before transplantation in patients with multiple Myeloma: a simple risk stratification system.
- Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple Myeloma.
- Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
- Morbidity and mortality of Deep sedation in outpatient bone marrow biopsy.
- Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing Peripheral bl...
- Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
- Superior survival in primary systemic amyloidosis patients undergoing Peripheral blood stem cell transplantation: a case-control study.
- Transfusion medicine illustrated: cold agglutinin Disease.
- Erroneous erythromelalgia.
- Posttransplantation thrombotic Thrombocytopenic purpura: a single-center experience and a contemporary review.
- Stem cell transplantation for the management of primary systemic amyloidosis.
- A method for identification and analysis of non-overlapping Myeloid immunophenotypes in humans.
Schools
Mayo Medical School
Mayo Clinic Rochester
University Ia
Mayo Grad School Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Aortic Embolism and Thrombosis
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
University of Iowa Hospitals and Clinics -
Mayo Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota -
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1487633988 | |
| NPPES Provider LastName | GASTINEAU | |
| NPPES Provider FirstName | DENNIS | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 94.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487633988 |
| Last Name Of The Provider | GASTINEAU |
| First Name Of The Provider | DENNIS |
| View All |
Similar Doctors
|
|
Dr. William J. Hogan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip R. Greipp, MD |
|
|
Dr. Aref Al-Kali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela Dispenzieri, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ryan E. Wilcox, MD |
|
|
Dr. Brian J. Davis, MD |
|
|
Dr. Amie E. Jackson, MD |
|
|
Dr. Pashtoon M. Kasi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Luis F. Porrata, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Andreas S. Beutler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Russell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nanna H. Sulai, MD |
|
|
Dr. Muhammad A. Mir, MD |